Back to Search
ANDREW MILLER, MD
MD
Interventional Cardiology Physician
NPI: 1942264932IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G5379(TX)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
G5379(TX)
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1983
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
Public-academic partnerships: research in community mental health settings: a practicum experience for researchers.
PMID 18971398·Psychiatr Serv·2008
8-other
Translation towards personalized medicine in Multiple Sclerosis.
PMID 18789804·J Neurol Sci·2008
6-review
Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
PMID 18304693·Ann Emerg Med·2008
4-observational
Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids.
PMID 18045478·Cancer Cell Int·2007
8-other
Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
PMID 17606285·Steroids·2007
4-observational
Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.
PMID 17433820·J Neurol Sci·2007
6-review
The influence of pulleys on the quantitative characteristics of medial rectus muscle recessions: the torque vector model.
PMID 16935230·J AAPOS·2006
8-other
Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies.
PMID 16674978·J Neurol Sci·2006
6-review
Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status.
PMID 16468081·Qual Life Res·2006
8-other
Health-related quality of life in multiple sclerosis: psychometric analysis of inventories.
PMID 16042229·Mult Scler·2005
3-trial
Vitamin B12, demyelination, remyelination and repair in multiple sclerosis.
PMID 15896807·J Neurol Sci·2005
6-review
The Texas medication algorithm project: clinical results for schizophrenia.
PMID 15631256·Schizophr Bull·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1604 HOSPITAL PKWY, SUITE 301
BEDFORD, TX 76022 - Phone
- (817) 684-9970
Quick Facts
- NPI
- 1942264932
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 43
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile